Literature DB >> 11983592

Toxoplasma gondii tachyzoite-bradyzoite interconversion.

Russell E Lyons1, Rima McLeod, Craig W Roberts.   

Abstract

During infection in the intermediate host, Toxoplasma gondii undergoes stage conversion between the rapidly dividing tachyzoite that is responsible for acute toxoplasmosis and the slowly replicating, encysted bradyzoite stage. This process of tachyzoite-bradyzoite interconversion is central to the pathogenesis and longevity of infection. Recent research has identified several stage-specific genes and proteins. However, despite recent advances in the understanding of Toxoplasma cell biology, more research is necessary to elucidate the complex events occurring during tachyzoite-bradyzoite interconversion. Here, a brief summary of this process is provided and a new method to characterize gene expression during interconversion is introduced.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983592     DOI: 10.1016/s1471-4922(02)02248-1

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  66 in total

1.  PD-1-mediated attrition of polyfunctional memory CD8+ T cells in chronic toxoplasma infection.

Authors:  Rajarshi Bhadra; Jason P Gigley; Imtiaz A Khan
Journal:  J Infect Dis       Date:  2012-04-26       Impact factor: 5.226

2.  Activity of the histone deacetylase inhibitor FR235222 on Toxoplasma gondii: inhibition of stage conversion of the parasite cyst form and study of new derivative compounds.

Authors:  Danièle Maubon; Alexandre Bougdour; Yung-Sing Wong; Marie-Pierre Brenier-Pinchart; Aurélie Curt; Mohamed-Ali Hakimi; Hervé Pelloux
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

3.  The Skp1 protein from Toxoplasma is modified by a cytoplasmic prolyl 4-hydroxylase associated with oxygen sensing in the social amoeba Dictyostelium.

Authors:  Yuechi Xu; Kevin M Brown; Zhuo A Wang; Hanke van der Wel; Crystal Teygong; Dongmei Zhang; Ira J Blader; Christopher M West
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

4.  Histone-modifying complexes regulate gene expression pertinent to the differentiation of the protozoan parasite Toxoplasma gondii.

Authors:  Nehmé Saksouk; Micah M Bhatti; Sylvie Kieffer; Aaron T Smith; Karine Musset; Jérôme Garin; William J Sullivan; Marie-France Cesbron-Delauw; Mohamed-Ali Hakimi
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

5.  Differential subcellular localization of members of the Toxoplasma gondii small heat shock protein family.

Authors:  N de Miguel; P C Echeverria; S O Angel
Journal:  Eukaryot Cell       Date:  2005-12

6.  Evaluation of the Protective Effect of Deoxyribonucleic Acid Vaccines Encoding Granule Antigen 2 and 5 Against Acute Toxoplasmosis in BALB/c Mice.

Authors:  Xiao Teng Ching; Mun Yik Fong; Yee Ling Lau
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

7.  Use of MAG1 recombinant antigen for diagnosis of Toxoplasma gondii infection in humans.

Authors:  Lucyna Holec; Elzbieta Hiszczyńska-Sawicka; Artur Gasior; Anna Brillowska-Dabrowska; Józef Kur
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

8.  A Toxoplasma gondii leucine-rich repeat protein binds phosphatase type 1 protein and negatively regulates its activity.

Authors:  Wassim Daher; Gabrielle Oria; Sylvain Fauquenoy; Katia Cailliau; Edith Browaeys; Stanislas Tomavo; Jamal Khalife
Journal:  Eukaryot Cell       Date:  2007-07-27

9.  The phosphoproteomes of Plasmodium falciparum and Toxoplasma gondii reveal unusual adaptations within and beyond the parasites' boundaries.

Authors:  Moritz Treeck; John L Sanders; Joshua E Elias; John C Boothroyd
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

10.  Effect of rSAG-1(P30) immunisation on the circulating and tissue parasites in guinea pigs as determined by quantitative PCR.

Authors:  Pierre Flori; Laëtitia Tardy; Alain Jacquet; Bahrie Bellete; Jamal Hafid; Hélène Raberin; Roger Tran Manh Sung
Journal:  Parasitol Res       Date:  2006-01-17       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.